Ozone therapy as add-on treatment in fibromyalgia management by rectal insufflation: An open-label pilot study

Journal of Alternative and Complementary Medicine

Volumn 19, Issue 3, 2013, Pages 238-242

  Hidalgo Tallón, Javier ^a   Menéndez Cepero, Silvia ^b   Vilchez, Juan S ^a   Rodríguez López, Carmen M ^a,c   Calandre, Elena P ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^c UNIVERSITY OF ALMERÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OZONE;

ADD ON THERAPY; ADULT; AERATION; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONSTIPATION; DEPRESSION; DEPRESSION INVENTORY; DISEASE DURATION; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE; GENERATOR; HUMAN; MALE; METEORISM; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPEN STUDY; OUTCOME ASSESSMENT; OZONE THERAPY; PAIN; PILOT STUDY; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUESTIONNAIRE; SHORT FORM 12; STATE TRAIT ANXIETY INVENTORY; SYMPTOMATOLOGY; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADULT; AGED; ANXIETY; DEPRESSION; FEMALE; FIBROMYALGIA; HEALTH SURVEYS; HUMANS; INSUFFLATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); OZONE; PILOT PROJECTS; QUESTIONNAIRES; RECTUM; SLEEP; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84875423863     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2011.0739     Document Type: Article

References (41)

1. Saxena A, Solitar BM. Fibromyalgia: Knowns, unknowns and current treatment. Bull NJU Hosp Jt Dis 2010;68:157-161.
2. Ablin J, Neumann L, Buskila D. Pathogenesis of fibromyalgia: A review. Joint Bone Spine 2008;75:273-279.
3. Ozgocmen S, Ozyurt H, Sogut S, et al. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int 2006;26:598-603.
4. Iqbal R, Mughal MS, Arshad N, et al. Pathophysiology and antioxidant status of patients with fibromyalgia. Rheumatol Int 2011;31:149-152.
5. Bocci VA. Scientific and medical aspects of ozone therapy: The state of the art. Arch Med Res 2006;37:425-435.
6. Bocci V, Di Paolo N. Oxygen-ozone therapy in medicine: An update. Blood Purif 2009;28:373-376.
7. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-172.
8. Hernandez Rosales FA, Calunga Fernandez JL, Turrent Figueras J, et al. Ozone therapy effects on biomarkers and lung function in asthma. Arch Med Res 2005;36:559-554.
9. Menendez S, Cepero J, Borrego L. Ozone therapy in cancer treatment: State of the art. Ozo-Sci Eng 2008;30:398-404.
10. Mart?nez-Sanchez G, Al-Dalain SM, Menendez S, et al. Therapeutic efficacy of ozone medical treatments in patients with diabetic foot. Eur J Pharmacol 2005;523:151-161.
11. Copello M, Egu?a F, Menendez S, et al. Ozone therapy in patients with retinitis pigmentosa. Ozone Sci Eng 2003;25: 223-232.
12. Bocci V. Oxygen-Ozone Therapy. A critical evaluation. AH Dordrecht, The Netherlands: Kluwer Academic Publishers, 2002:243-341.
13. Note for guidance on clinical investigation of medicinal products for treatment of nociceptive pain. November 2002. Online document at: www.ema.europa.eu/ema/index.jsp?curl=pages/includes/document/document-detail. jsp?web ContentId=WC500003525&mid=WC0b01ac058009a3dc Accessed January 21, 2012.
14. Rivera J, Gonzalez T. The Fibromyalgia Impact Questionnaire: A validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 2004;22:554-460.
15. Vazquez C, Sanz J. Reliability and normal values of the Spanish version of the Beck Depression Inventory of 1978. [in Spanish]. Clin Salud 1997;8:403-422.
16. Royuela A, Mac?as JA. Clinimetric properties of the Spanish version of the Pittsburgh Sleep Quality Index. [in Spanish]. Vigilia Sueno 1997;9:81-94.
17. Spielberger CD, Gorsuch RL, Lushene RE. State and Trait Anxiety Inventory (STAI). Manual (60th edition). [in Spanish]. Publicaciones de Psicolog?a Aplicada. Serie menor n-124. Madrid: TEA Ediciones S.A., 2002.
18. Institut Municipal d'Investigacio Medica. Biblio Pro: Technical data of the instrument SF-12. [in Spanish]. Online document at: http://iryss.imim.es/ iryss/new-ficha.asp?id=243. Accessed January 7, 2012.
19. Bennet RM, Bushmakin AG, Cappellari JC, et al. Minimally clinically important difference in the fibromyalgia Impact Questionnaire. J Rheumatol 2009;36:1304-1311.
20. Mease PJ, Spaeth M, Clauw DJ, et al. Estimation of minimum clinically important difference for pain in fibromyalgia. Arthritis Care Res 2011;63:821-826.
21. Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain: IMMPACT recommendations. J Pain 2008;9:105-121.
22. Borrelli E, Bocci V. A novel therapeutic option for chronic fatigue syndrome and fibromyalgia. Riv Ital Ossigeno Ozonoter 2002;1:149-153.
23. Schaible HG, Ebersberger A, von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci 2001;966:343-354.
24. Staud R, Vierck CJ Jr, Cannon RC, et al. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001;91:165-175.
25. Bengtsson A. The muscle in fibromyalgia. Rheumatology 2002;41:721-724.
26. Chung CP, Titova D, Oeser A, et al. Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatol 2009;28:435-438.
27. Bagis S, Tamer L, Sabin G, et al. Free radicals and antioxidants in primary fibromyalgia: An oxidative stress disorder. Rheumatol Int 2005;25:188-190.
28. Lund N, Bengtsson A, Thorborg P. Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 1986;15:165-173.
29. Jeschonneck M, Grohmann G, Hein G, et al. Abnormal microcirculation and temperature in skin above tender points in patients with fibromyalgia. Rheumatology 2000;39:917-921.
30. Bengtsson A, Henriksson KG, Larsson J. Reduced high energy phosphate levels in the painful muscles of patients with primary fibromyalgia. Arthritis Rheum 1986;15:1-6.
31. Cordero MD, de Miguel M, Carmona-Lopez I, et al. Oxidative stress and mitochondrial dysfunction in fibromyalgia. Neuro Endocrinol Lett 2010;31:169-73.
32. Cordero MD, Moreno-Fernandez AM, Carmona-Lopez MI, et al. Mitochondrial dysfunction in skin biopsies and blood mononuclear cells from two cases of fibromyalgia patients. Clin Biochem 2010;43:1174-1176.
33. Wallace DJ, Linker-Israeli M, Hallegua D, et al. Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumatology 2001;40:743-749.
34. Al-Dalain SM, Mart?nez G, Candelario-Jalil E, et al. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res 2001;44:391-396.
35. Candelario-Jalil E, Mohammed-Al-Dalain S, Leon OS, et al. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol 2001;21:297-301.
36. Leon OS, Ajamieh HH, Berlanga J, et al. Ozone oxidative preconditioning is mediated by A1 receptors in a rat model of liver ischemia/reperfusion. Transpl Int 2008;21: 39-48.
37. Calunga JL, Trujillo Y, Menendez S, et al. Ozone oxidative postconditioning in acute renal failure. J Pharm Pharmacol 2009;61:1-7.
38. Ajamieh HH, Menendez S, Mart?nez-Sanchez G, et al. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int 2004;24:55-62.
39. Zamora Z, Borrego A, Lopez O, et al. Effects of ozone oxidative preconditioning on TNF-a release and antioxidantprooxidant intracellular balance in mice during endotoxic shock. Mediat Inflamm 2005;1:16-22.
40. Ajamieh HH, Berlanga J, Merino N, et al. Role of protein synthesis in the protection conferred by ozone-oxidativepreconditioning hepatic ischaemia/reperfusion. Transpl Int 2005;18:604-612.
41. Leon OS, D?az-Soto MT, Fraga A, et al. Ozone oxidative postconditioning protects against the injury associated with alcohol withdrawal syndrome [Abstract]. Proceedings of the 20th Ozone World Congress, May 23-27, 2011, Paris, Franc.e.